Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Keryx Biopharmaceuticals Inc. (KERX)

13.46 Down 0.46(3.30%) Apr 17, 4:00PM EDT
|After Hours : 13.35 Down 0.11 (0.82%) Apr 17, 7:53PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
Apr 17, 2014New Constructs, LLCN/AKERX: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 17, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of KERYX BIOPHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 17, 2014S&P Capital IQ Quantitative ReportN/AKeryx Biopharmaceuticals11$126.50
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for KERX11$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 11, 2014Pechala's ReportsFrantisek PechalaKERYX BIOPHARMACEUTICALS INC (KERX) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: BIOD , INFI , ICPT , KERX , PBYI , SNTA -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: KERYX BIOPHARM -- KERX1$11.50
Apr 4, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Keryx Biopharmaceuticals, Inc.41$75
Mar 31, 2014Zacks Investment Research Inc.N/AKERYX BIOPHARMA (KERX) Zacks Company Snapshot1$11.50

View All Reports for KERX ...